Mirae Asset Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹8161 Cr | ₹2652 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 02 Jul 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 15% |
Expense Ratio | 1.82 | 1.92 |
Manager | Sailesh Raj Bhan | Vrijesh Kasera |
ISIN Code | INF204K01968 | INF769K01EA2 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Month | -6% | -7.01% |
6 Month | -8.47% | -8.33% |
1 Year | 6.77% | 10.68% |
3 Year | 18.71% | 17.04% |
5 Year | 22.93% | 23.32% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
6 Month | - | - |
1 Year | -2.3% | -0.02% |
3 Year | 21.23% | 20.88% |
5 Year | 19.2% | 19.03% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Year | 18.19% | 24.74% |
3 Year | 20.5% | 19.07% |
5 Year | 20.36% | 24.52% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Standard Deviation | 15.185% | 16.034% |
Sharp | 0.81% | 0.71% |
Beta | 0.931% | 0.987% |
Alpha | -0.33% | -1.971% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Name | Sailesh Raj Bhan | Vrijesh Kasera |
Total AUM | ₹96086 Cr | ₹12061 Cr |
Fund Manage | 5 | 4 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 4.4 | 0.92 |
Large Cap | 45.96 | 43.94 |
Mid Cap | 27.12 | 34.94 |
Small Cap | 22.52 | 20.21 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 4.4 | 0.92 |
Pharmaceuticals & Biotechnology | 75.86 | 81.65 |
Healthcare Services | 17.38 | 16.07 |
Retailing | 2.36 | - |
Chemicals & Petrochemicals | - | 1.37 |
Top Comparisons
Templeton India Equity Income Fund-Growth Plan
3Y Returns17.32%
SBI Dividend Yield Fund - Regular Plan - Growth
3Y Returns0%
Franklin India Multi - Asset Solution Fund of Funds- Growth Plan
3Y Returns10.86%
HSBC Managed Solutions - Moderate - Growth
3Y Returns10.21%
Invesco India Money Market Fund - Growth
3Y Returns6.28%
Axis Money Market Fund - Regular Plan - Growth Option
3Y Returns6.77%
Tata Multicap Fund - Regular Plan - Growth
3Y Returns0%
Tata Multicap Fund - Regular Plan - Growth
3Y Returns0%